Disturbance of B-vitamin status in people with type 2 diabetes in Indonesia-Link to renal status, glycemic control and vascular inflammation

Diabetes Research and Clinical Practice

Volumn 95, Issue 3, 2012, Pages 415-424

  Adaikalakoteswari, Antonysunil ^a   Rabbani, Naila ^a   Waspadji, Sarwono ^b   Tjokroprawiro, Askandar ^c   Kariadi, Sri H K S ^d   Adam, John M F ^e   Thornalley, Paul J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF INDONESIA   (Indonesia)

^c AIRLANGGA UNIVERSITY   (Indonesia)

^d PADJADJARAN UNIVERSITY   (Indonesia)

^e HASANUDDIN UNIVERSITY   (Indonesia)

Author keywords

Cobalamin; Diabetic nephropathy; Folate; Pyridoxine; Thiamine; Type 2 diabetes; Vascular inflammation

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; COBALAMIN; CREATININE; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; GLUCOSE; HALOTRANSCOBALAMIN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; PYRIDOXIC ACID; PYRIDOXINE; SULFONYLUREA; THIAMINE; UNCLASSIFIED DRUG; VITAMIN B GROUP; VITAMIN B9;

ADULT; ALBUMINURIA; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; DRUG BLOOD LEVEL; DRUG ERYTHROCYTE LEVEL; DRUG EXCRETION; DRUG URINE LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; INDONESIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; VASCULITIS; VITAMIN DEFICIENCY; VITAMIN SUPPLEMENTATION;

ALBUMINURIA; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; HUMANS; INDONESIA; INFLAMMATION; THIAMINE; VASCULAR DISEASES; VITAMIN B COMPLEX;

EID: 84857234415     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.10.042     Document Type: Article

References (50)

1. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
2. Parving H.H., Lewis J.B., Ravid M., Remuzzi G., Hunsicker L.G. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006, 69:2057-2063.
3. Wu A.Y.T., Kong N.C.T., de Leon F.A., Pan C.Y., Tai T.Y., Yeung V.T.F., et al. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 2005, 48:17-26.
4. Nielsen S.E., Sugaya T., Hovind P., Baba T., Parving H.H., Rossing P. Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients. Diabetes Care 2010, 33:1320-1324.
5. de Zeeuw D., Remuzzi G., Parving H.H., Keane W.F., Zhang Z., Shahinfar S., et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004, 110:921-927.
6. Rabbani N., Shahzad Alam S., Riaz S., Larkin J.R., Akhtar M.W., Shafi T., et al. High dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a pilot randomised, double-blind, placebo-controlled study. Diabetologia 2009, 52:208-212.
7. Sihag B., Meena B., Agrawal R., Meel J., Sirohi P., Bishnoi P. High dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled study. Diabetes Obes Metab 2010, 12:87-88.
8. Thornalley P.J., Babaei-Jadidi R., Al Ali H., Rabbani N., AntonySunil A., Ahmed A., et al. High prevalence of low plasma thiamine concentration in diabetes linked to marker of vascular disease. Diabetologia 2007, 50:2164-2170.
9. Friedman A.N., Hunsicker L.G., Selhub J., Bostom A.G. Clinical and nutritional correlates of C-reactive protein in type 2 diabetic nephropathy. Atherosclerosis 2004, 172:121-125.
10. MacKenzie K.E., Wiltshire E.J., Gent R., Hirte C., Piotto L., Couper J.J. Folate and vitamin B-6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus. Pediatrics 2006, 118:242-253.
11. Herrmann W., Schorr H., Obeid R., Makowski J., Fowler B., Kuhlmann M.K. Disturbed homocysteine and methionine cycle intermediates S-adenosylhomocysteine and S-adenosylmethionine are related to degree of renal insufficiency in type 2 diabetes. Clin Chem 2005, 51:891-897.
12. Lonn E., Yusuf S., Arnold M.J., Sheridan P., Pogue J., Micks M., et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. New Engl J Med 2006, 354:1567-1577.
13. House A.A., Eliasziw M., Cattran D.C., Churchill D.N., Oliver M.J., Fine A., et al. Effect of B-vitamin therapy on progression of diabetic nephropathy a randomized controlled trial. JAMA 2010, 303:1603-1609.
14. Wulffele M.G., Kooy A., Lehert P., Bets D., Ogterop J.C., Burg B., et al. Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med 2003, 254:455-463.
15. de Jager J., Kooy A., Lehert P., Wulffele M.G., van der Kolk J., Bets D., et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. Br Med J 2010, 340.
16. Thornalley P.J., Rabbani N., Therapy Vitamin B6, B9 and B12 in diabetic nephropathy-beware. Nat Rev Endocrinol 2010, 6:477-478.
17. Koyama K., Yoshida A., Takeda A., Morozumi K., Fujinami T., Tanaka N. Abnormal cyanide metabolism in uraemic patients. Nephrol Dial Transplant 1997, 12:1622-1628.
18. Asian-Pacific Type 2 Diabetes Policy Group and International Diabetes Federation Type 2 diabetes. Practical targets and treatments 2005, International Diabetes Institute, pp. 1-62. 4th ed.
19. Maschio G., Oldrizzi L., Rugiu C. Is there a point-of-no-return in progressive renal-disease. J Am Soc Nephrol 1991, 2:832-840.
20. Bisp M.R., Bor M.V., Heinsvig E.M., Kall M.A., Nexo E. Determination of vitamin B6 vitamers and pyridoxic acid in plasma: development and evaluation of a high-performance liquid chromatographic assay. Anal Biochem 2002, 305:82-89.
21. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
22. Comper W.D., Osicka T.M., Clark M., MacIsaac R.J., Jerums G. Earlier detection of micro albuminuria in diabetic patients using a new urinary albumin assay. Kidney Int 2004, 65:1850-1855.
23. Chudleigh R., Ollerton R., Dunseath G., Peter R., Harvey J., Luzio S., et al. Use of cystatin C-based estimations of glomerular filtration rate in patients with type 2 diabetes. Diabetologia 2009, 52:1274-1278.
24. American Diabetes Association Standards of Medical Care in Diabetes-2010. Diabetes Care 2010, 33:S11-S61.
25. Joshi R., Jan S., Wu Y., MacMahon S. Global inequalities in access to cardiovascular health care: our greatest challenge. J Am Coll Cardiol 2008, 52:1817-1825.
26. Herrmann W., Obeid R., Causes Early diagnosis of vitamin B(12) deficiency. Dtsch Arztebl Int 2008, 105:680-685.
27. Babaei-Jadidi R., Karachalias N., Ahmed N., Battah S., Thornalley P.J. Prevention of incipient diabetic nephropathy by high dose thiamine and benfotiamine. Diabetes 2003, 52:2110-2120.
28. Rabbani N., Thornalley P.J. Emerging role of thiamine therapy for prevention and treatment of early-stage diabetic nephropathy. Diabetes Obes Metab 2011, 13:577-583.
29. Ihara H., Matsumoto T., Kakinoki T., Shino Y., Hashimoto R., Hashizume N. Estimation of vitamin B1 excretion in 24-hr urine by assay of first-morning urine. J Clin Lab Anal 2008, 22:291-294.
30. Tasevska N., Runswick S.A., McTaggart A., Bingham S.A. Twenty-four-hour urinary thiamine as a biomarker for the assessment of thiamine intake. Eur J Clin Nutr 2007, 62:1139-1147.
31. AntonySunil A., Perkins B., Krolewski A., Rabbani N., Thornalley P.J. Thiamine status and risk of early renal function decline in type 1 diabetic patients. Diabetologia 2008, 51:S98.
32. Larkin J.R., Rabbani N., Zehnder D., Thornalley P.J. Down regulation of thiamine transporter expression in human tubular epithelial cells in vitro and increased thiamine clearance in diabetes. Diabetes 2011, 60:A1.
33. Coburn S.P. Location and turnover of vitamin B6 pools and vitamin B6 requirements of Humansa. Ann N Y Acad Sci 1990, 585:76-85.
34. Schuster K., Bailey L.B., Cerda J.J., Gregory J.F. Urinary 4-pyridoxic acid excretion in 24-hour versus random urine samples as a measurement of vitamin B6 status in humans. Am J Clin Nutr 1984, 39:466-470.
35. Merrill A.H., Henderson J.M., Wang E., McDonald B.W., Millikan W.J. Metabolism of vitamin B-6 by human liver. J Nutr 1984, 114:1664-1674.
36. Nexo E., Hoffmann-Lucke E. Holotranscobalamin, a marker of vitamin B-12 status: analytical aspects and clinical utility. Am J Clin Nutr 2011, 94:359S-365S.
37. Solomon L.R. Diabetes as a cause of clinically significant functional cobalamin deficiency. Diabetes Care 2011, 34:1077-1080.
38. Vogiatzoglou A., Oulhaj A., Smith A.D., Nurk E., Drevon C.A., Ueland P.M., et al. Determinants of plasma methylmalonic acid in a large population: implications for assessment of vitamin B12 status. Clin Chem 2009, 55:2198-2206.
39. Refsum H., Johnston C., Guttormsen A.B., Nexo E. Holotranscobalamin and total transcobalamin in human plasma: determination, determinants, and reference values in healthy adults. Clin Chem 2006, 52:129-137.
40. Tessari P., Coracina A., Kiwanuka E., Vedovato M., Vettore M., Valerio A., et al. Effects of insulin on methionine and homocysteine kinetics in type 2 diabetes with nephropathy. Diabetes 2005, 54:2968-2976.
41. Kolb H., Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia 2010, 53:10-20.
42. Koga M., Otsuki M., Kubo M., Hashimoto J., Kasayama S. Relationship between circulating vascular cell adhesion molecule-1 and microvascular complications in Type 2 diabetes mellitus. Diabet Med 1998, 15:661-667.
43. Weber W., Kewitz H. Determination of thiamine in human plasma and its pharmacokinetics. Eur J Clin Pharmacol 1985, 28:213-219.
44. Ariaey-Nejad M.R., Balaghi M., Baker E.M., Sauberlich H.E. Thiamin metabolism in man. Am J Clin Nutr 1970, 23:764-778.
45. Cuskelly G.J., Stacpoole P.W., Williamson J., Baumgartner T.G., Gregory J.F. Deficiencies of folate and vitamin B6 exert distinct effects on homocysteine, serine, and methionine kinetics. Am J Physiol Endocrinol Metab 2001, 281:E1182-E1190.
46. Lamers Y., O'Rourke B., Gilbert L.R., Keeling C., Matthews D.E., Stacpoole P.W., et al. Vitamin B-6 restriction tends to reduce the red blood cell glutathione synthesis rate without affecting red blood cell or plasma glutathione concentrations in healthy men and women. Am J Clin Nutr 2009, 90:336-343.
47. Heyssel R.M., Bozan R.C., Darby W.J., Bell M.C. Vitamin B12 turnover in man: the assimilation of vitamin B12 from natural foodstuff by man and estimates of minimal daily dietary requirements. Am J Clin Nutr 1966, 18:176-184.
48. Nexo E., Hvas A.M., Bleie O., Refsum H., Fedosov S.N., Vollset S.E., et al. Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study. Clin Chem 2002, 48:1768-1771.
49. Mihardja L., Delima, Siswayo H., Ghani L., Soegondo S. Prevalence and determinants of diabetes mellitus and impaired glucose tolerance in Indonesia. Acta Med Indones 2009, 41:169-174.
50. Schwartz M.M., Lewis E.J., Leonard-Martin T., Lewis J.B., Batlle D. Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group. Nephrol Dial Transplant 1998, 13:2547-2552.